Drug intelligence / Profile preview

Regulax

Development stage
Unknown
Lead developer
Krewel Meuselbach
Modality
Small Molecules
Administration
Oral
01

Overview

Regulax is a brand of stimulant laxatives developed and marketed by the German pharmaceutical company Krewel Meuselbach. The product line is primarily known for its herbal formulation, **Regulax Abführ-Würfel** (laxative cubes), which contains sennosides derived from Senna leaves and fruits. These sennosides act as prodrugs that are metabolized by colonic bacteria into active rheinanthrones. These active metabolites stimulate the myenteric plexus to increase colonic motility (peristalsis) and inhibit water and electrolyte reabsorption by modulating the activity of the Na+/K+-ATPase pump and downregulating aquaporin 3 channels. Another variant, **Regulax Picosulfat**, utilizes sodium picosulfate, which is similarly activated by bacterial enzymes in the gut to exert a stimulant effect. Regulax is indicated for the short-term treatment of occasional constipation and is available as an over-the-counter (OTC) medication.

Brand names
RegulaxRegulax Abführ-WürfelRegulax Picosulfat
Other names
sennosidessodium picosulfate
02

Targets

AQP3 (Aquaporin-3 channel protein)ATP1A (Sodium/potassium-transporting ATPase)

Beyond the preview

Go deeper on Regulax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call